India’s medical device sector has witnessed significant growth over the last few years, with an increasing number of manufacturers expanding into international markets across Asia, Africa, Europe, the Middle East, and Latin America. Along with product quality, manufacturing capability, and regulatory compliance, export documentation now plays a critical role in supporting global market access activities.
Among the various regulatory documents requested during overseas product registration and import approval processes, the Free Sale Certificate (FSC) remains one of the most important requirements for medical device exporters from India.
In many countries, regulatory authorities and importers require an FSC before permitting product registration, commercial import, or distributor authorization. Without the certificate, manufacturers may face delays in overseas registration processes, customs clearance activities, or market entry timelines.
For companies planning exports, understanding the FSC process early in the regulatory and commercialization stage can help avoid unnecessary complications later during international expansion activities.
What is a Free Sale Certificate (FSC)?
A Free Sale Certificate is an official regulatory document issued by the Central Drugs Standard Control Organization (CDSCO) or the applicable State Licensing Authority confirming that a medical device is legally manufactured and permitted for sale or distribution in India.
The certificate acts as regulatory evidence that:
- The manufacturer holds a valid manufacturing license
- The product complies with applicable Medical Devices Rules
- The medical device is legally marketed in India
- The product is approved for commercial sale or distribution
The FSC is primarily intended for export-related activities and is commonly requested during:
- Overseas product registration
- Import license applications
- Distributor onboarding
- Government tenders
- Customs clearance procedures
- International market expansion activities
- Foreign regulatory submissions
Several international regulatory authorities consider the FSC as part of the core documentation package during evaluation of imported medical devices.
Why is the FSC Important for Medical Device Export?
When a foreign regulatory authority evaluates a medical device for import registration, one of the key expectations is confirmation that the product is already regulated and legally sold in the country of origin.
The FSC provides that regulatory assurance.
For overseas authorities, the certificate demonstrates that:
- The manufacturer operates under a recognized regulatory framework
- The product has undergone licensing review
- The device is not unauthorized or illegally marketed
- The manufacturer is functioning under regulatory oversight
In many markets, the FSC is requested along with:
- ISO 13485 certificate
- Product labeling
- Technical documentation
- Declaration of conformity
- Device master documentation
- Clinical or performance information
Manufacturers planning exports should therefore consider FSC readiness as part of their broader global regulatory strategy.
Official CDSCO Guidance on FSC
CDSCO has issued an official guidance document titled:
According to the guidance document, the FSC process is applicable to Indian medical device manufacturers holding valid manufacturing licenses who intend to export medical devices.
The application process is conducted online through www.cdscomdonline.gov.in
Manufacturers should always refer to the latest CDSCO guidance and portal requirements before initiating submissions.
Which Authority Issues the FSC?
One of the most common areas of confusion among manufacturers is identifying the correct authority responsible for issuing the FSC.
The applicable authority depends on the classification of the medical device under the Medical Devices Rules, 2017.
Applications for the following categories are submitted to the respective State Licensing Authority (SLA):
- Class A medical devices
- Class B medical devices
Applications for the following categories are submitted to the Central Licensing Authority (CLA) under CDSCO:
- Class C medical devices
- Class D medical devices
Manufacturers should ensure proper classification assessment before submission, as incorrect authority selection can delay application processing.
This becomes particularly important for borderline products where classification interpretation may require careful regulatory review.
Preparatory Activities Before FSC Submission
Before initiating the FSC application, manufacturers should internally review their regulatory documentation and licensing status.
In many practical situations, delays occur not because of complex regulatory issues, but due to inconsistencies between:
- Manufacturing licenses
- Product names
- Brand names
- Labels
- Product variants
- Technical documentation
- Application forms
Manufacturers should verify that:
- The manufacturing license remains valid
- Product details are updated
- Device variants are correctly listed
- Product names are consistent across documents
- Labeling aligns with approved information
Early internal review can significantly reduce avoidable regulatory deficiencies during submission.
FSC Application Process
The FSC application is submitted online through the CDSCO MD Online Portal.
The general process includes:
- Login to the CDSCO portal
- Selection of FSC application section
- Completion of application details
- Selection of applicable medical devices
- Upload of required supporting documents
- Upload of legal undertaking
- Payment of applicable government fees
- Final online submission
Although the process is digital, manufacturers should ensure careful document review before submission, particularly when multiple products or variants are involved.
Covering Letter Requirements
As part of the FSC application, manufacturers are required to submit a covering letter clearly explaining the purpose of the submission.
According to CDSCO guidance, the covering letter should include:
- Purpose of the application
- Product details
- List of enclosed documents
- Relevant regulatory information
The letter should also contain:
- Name of authorized signatory
- Designation
- Firm address
- Signature and company stamp
A properly drafted covering letter often helps present the submission clearly during regulatory review.
FSC Application Form
The system-generated FSC application form should correctly reflect:
- Manufacturing license number
- Product list for which FSC is requested
Manufacturers should carefully review the brand names, device variants, model numbers, and product descriptions before submission to ensure consistency across the application and manufacturing license documentation. In practice, even minor mismatches between the FSC application and approved license records are among the common reasons for clarification requests from regulatory authorities.
Government Fees for FSC
As per the current CDSCO guidance document, the government fee for issuance of a Free Sale Certificate (FSC) is INR 1000 per category of medical device. The fee is paid through the Bharatkosh online payment system, and the challan receipt generated after payment must be uploaded along with the application. Manufacturers should ensure that the payment details and uploaded challan are accurate, as errors in fee payment or challan submission can lead to delays during application review.
Manufacturing License Requirement
A valid manufacturing license issued under the Medical Devices Rules, 2017 must be submitted as part of the FSC application. Before submission, manufacturers should verify that the license remains valid, the applied products are covered under the approved license, and any applicable retention-related information is properly updated. In many cases, expired licenses or inconsistencies in licensing records can result in delays during FSC review and approval.
Legal Undertaking Requirement
One of the important requirements under the FSC guidance is submission of a legal undertaking by the manufacturer. As per CDSCO guidance, the undertaking must be recently notarized and submitted on INR 100 stamp paper. The document confirms that no regulatory action has been initiated against the manufacturer and that there are no pending adverse events, unresolved market complaints, or Not of Standard Quality (NSQ) reports associated with the products included in the FSC application.
The undertaking should include the manufacturing license details, list of applied products, authorized signatory information, and notary authentication. Manufacturers should ensure that the undertaking is properly drafted, accurately reflects the applied products, and is recently notarized before submission as part of the FSC application package.
Important Regulatory Point Regarding Export-Only Products
An important clarification provided in the CDSCO guidance document is that:
The FSC may not be granted for the product(s) that are meant exclusively for export purposes.
Manufacturers should therefore ensure that products included in the FSC application are also permitted for sale or distribution within India.
This is an important consideration for companies manufacturing products solely for overseas customers.
Validity of FSC
According to the CDSCO guidance document:
The FSC issued by the Licensing Authority is valid upto the validity of the manufacturing license…
However, the validity remains subject to the condition that no regulatory action has been initiated against the applied products.
Manufacturers should therefore maintain ongoing regulatory compliance even after FSC issuance.
Common Challenges Faced During FSC Applications
Although the FSC process is relatively structured, manufacturers often encounter delays due to:
- Incorrect device classification
- Incomplete documentation
- Product information mismatch
- Incorrect authority selection
- Payment-related issues
- Outdated licenses
- Label inconsistencies
- Delayed notarization activities
In practical situations, even small inconsistencies between product labels and manufacturing licenses can result in clarification requests. Proper regulatory review before submission can help minimize such avoidable delays.
Regulatory References
The FSC process is governed under:
- Medical Devices Rules, 2017 (G.S.R. 78(E), dated 31.01.2017)
- Gazette Notification G.S.R. 318(E), dated 18.04.2019
Manufacturers may also refer to:
- CDSCO FSC Guidance Document (CDSCO/MD/GD/FSC/02/2024)
- CDSCO Medical Device Portal
- Medical Devices Rules, 2017
How MedOrdyn Solutions Supports Medical Device Manufacturers
At MedOrdyn, we support medical device manufacturers with regulatory and compliance activities related to:
- Free Sale Certificate applications
- CDSCO regulatory support
- Medical device classification
- Manufacturing license support
- Technical documentation review
- Labeling compliance review
- Global market access activities
Conclusion
For medical device manufacturers involved in international exports, the Free Sale Certificate remains an important regulatory document supporting overseas product registration and market access activities.
Although the FSC process is procedural in nature, successful approval depends heavily on proper documentation, correct classification, regulatory consistency, and alignment with CDSCO expectations.
Manufacturers who proactively review their regulatory documentation and licensing status before submission are generally better positioned to support smoother export registration activities and reduce avoidable regulatory delays during global market expansion.
